Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
45%(5 trials)

Phase Distribution

Ph phase_1
6
43%
Ph not_applicable
4
29%
Ph phase_2
3
21%
Ph phase_3
1
7%

Phase Distribution

6

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
6(42.9%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Enrolling by invitation1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (42.9%)
Phase 23 (21.4%)
Phase 31 (7.1%)
N/A4 (28.6%)

Trials by Status

enrolling_by_invitation17%
unknown17%
withdrawn17%
completed1179%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DRUG
Total Trials
14